Industry Insights
-
Method Transfer – When, Why, How?
2/16/2022
A formal method transfer is an exercise that demonstrates and documents that a method has been successfully qualified in another laboratory to provide accurate and repeatable results.
-
Stressing Cells: The Role Of Cryoprotectants In ATMP Cryopreservation
3/7/2024
Explore the challenges of adding cryoprotectants, how they can help reduce the effects of harmful conditions like ice crystals, and the need for future stability studies and substitutes for toxic CPAs.
-
Helpful Biosafety Testing Innovations Where And When You Need Them
4/24/2025
Monoclonal antibody manufacturing is advancing to boost efficiency, cut costs, and expand access, driven by innovation, demand, and the rise of biosimilars.
-
Finding The Talent To Fuel Biopharma Breakthroughs
2/13/2024
Explore findings from research into talent pool resilience in the biopharmaceutical industry that incorporate survey insights as well as external data to ensure a more accurate overview.
-
Development And Manufacture Of A Highly Potent OSD Product
10/20/2025
Highly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.
-
Market Tumult And The Need For Creative Funding For Life Sciences
6/29/2022
Life sciences companies have not been immune to the upheaval in the financial markets, casting a pall over equity financing in the sector. Your company will need to be creative in raising capital. This article also covers M&A, synthetic royalty agreements, convertible debt, and covenants. Will there be a reckoning?
-
Conquering Challenges In Viral Vector Production
8/27/2025
Scaling gene therapy demands precision and actionable data. Discover how integrated technologies like ultracentrifugation and mass spectrometry enhance AAV yield, purity, and characterization.
-
Guide To PUPSIT And Annex 1 In Aseptic Processing
12/5/2024
Pre-use, post-sterilization integrity testing (PUPSIT) ensures filters remain undamaged and effective during aseptic manufacturing. Discover how you can successfully perform PUPSIT with proven solutions.
-
Safeguarding Biologic Integrity Through Enhanced Component Compatibility
2/4/2026
For sensitive biologics and viral vectors, risk extends beyond simple contamination. Utilizing inert barrier films on contact surfaces reduces compound migration and adsorption, maintaining dosage accuracy.
-
How Strong Intellectual Property Laws Keep Tennessee's Health Innovation Humming
1/22/2026
Strong IP protections drive Tennessee’s biotech growth by attracting investment, supporting research, fostering collaboration, and enabling innovators to deliver new therapies and technologies to patients.